BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 13, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for May 5, 2022

May 5, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cannvalate, Clover, Editas Medicine, Iqvia, Lanova, Lumos, Microba, Olix, Oxurion, Phathom, Phosplatin, South, Tetra, Tikomed, Turning.
Read More
Global vaccine.png

WTO’s IP waiver reaches final stretch

May 4, 2022
By Mari Serebrov
A proposal hammered out by the EU, India, South Africa and the U.S. to allow IP waivers for COVID-19 vaccines is headed to all members of the World Trade Organization (WTO) for consideration.
Read More
Global vaccine illustration

As COVID numbers drop, biopharma research remains steadfast

May 4, 2022
By Karen Carey
For the first time since the early weeks of the COVID-19 pandemic in 2020, global deaths caused by the disease have fallen to their lowest point, as immunity against the SARS-CoV-2 virus and its variants continues to build. Infections and deaths appear to be decelerating, an optimistic sign that the pandemic may be nearing an end.
Read More

Other news to note for May 4, 2022

May 4, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abeona, Adial, Asceneuron, Aura, Betta, Botanix, Brickell, Cero, Cognition, Eyepoint, Helsinn, Juniper, Nordic Nanovector, Spero.
Read More

Regulatory actions for May 3, 2022

May 3, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Axsome, Biogen, Coherus, Horizon, Hutchmed, Ideaya, Junshi, Moderna, Myovant, Novavax, Regeneron, Sage, Supernus, Vaxxinity, Vertex, Vitti.
Read More

In the clinic for May 3, 2022

May 3, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Aptorum, Kala, Milestone, Sorrento, Tarsus, Vertex, Zynerba.
Read More

Regulatory actions for May 2, 2022

May 2, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bristol Myers Squibb, Finch, Gilead, Merck, Moderna, Pfizer.
Read More

Other news to note for May 2, 2022

May 2, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aethlon, Amniotics, Allinaire, Annovis, Antibe, Aptinyx, Astrazeneca, Beigene, Biocytogen, Bonus, Chiesi Farmaceutici, Citagenix, Dragonfly, Elicio, Endo, First Wave, Gelesis, Gilead, Hansamed, Harpoon, Healion, Héra, Hikma, Incyte, Intellia, Intravacc, Ionova, Maruho, Merck, Moderna, Nevakar, Opiant, Perrigo, Ring, Roche, Surrozen, Virica, Zhifei Lvzhu, Zucara.
Read More

In the clinic for May 2, 2022

May 2, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Denali, First Wave, Galera, Innate, Lyra, Novo Nordisk, Rezolute, Roche, Stealth, Timber.
Read More

Regulatory actions for April 29, 2022

April 29, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Beigene, Cara, CNS, Janssen, Jasper, Moderna, Mycovia, Nevakar, SQZ, Timber, Vifor, Xbiotech.
Read More
Previous 1 2 … 109 110 111 112 113 114 115 116 117 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 12, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • LINC01116 has prognostic value in lung cancer, study shows

    BioWorld Science
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing